- Zhou, Ruo-Nan;
- Zhu, Zi-Wei;
- Xu, Ping-Yuan;
- Shen, Li-Xuan;
- Wang, Ziwei;
- Xue, Ying-Ying;
- Xiang, Ying-Ying;
- Cao, Yue;
- Yu, Xi-Zhong;
- Zhao, Juan;
- Jin, Yu;
- Yan, Jing;
- Yang, Qin;
- Fang, Peng-Hua;
- Shang, Wen-Bin
Rhein, a component derived from rhubarb, has been proven to possess anti-inflammatory properties. Here, we show that rhein mitigates obesity by promoting adipose tissue thermogenesis in diet-induced obese mice. We construct a macrophage-adipocyte co-culture system and demonstrate that rhein promotes adipocyte thermogenesis through inhibiting NLRP3 inflammasome activation in macrophages. Moreover, clues from acetylome analysis identify SIRT2 as a potential drug target of rhein. We further verify that rhein directly interacts with SIRT2 and inhibits NLRP3 inflammasome activation in a SIRT2-dependent way. Myeloid knockdown of SIRT2 abrogates adipose tissue thermogenesis and metabolic benefits in obese mice induced by rhein. Together, our findings elucidate that rhein inhibits NLRP3 inflammasome activation in macrophages by regulating SIRT2, and thus promotes white adipose tissue thermogenesis during obesity. These findings uncover the molecular mechanism underlying the anti-inflammatory and anti-obesity effects of rhein, and suggest that rhein may become a potential drug for treating obesity.